 Connection
Dianna Quan to Female
This is a "connection" page, showing publications Dianna Quan has written about Female.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.151 |
|
|
|
-
Aburahma SK, Wicklund MP, Quan D. Take two: Utility of the repeat skeletal muscle biopsy. Muscle Nerve. 2019 07; 60(1):41-46.
Score: 0.022
-
Fleming J, Quan D. A case of congenital spinal muscular atrophy with pain due to a mutation in TRPV4. Neuromuscul Disord. 2016 Dec; 26(12):841-843.
Score: 0.019
-
Moss M, Yang M, Macht M, Sottile P, Gray L, McNulty M, Quan D. Screening for critical illness polyneuromyopathy with single nerve conduction studies. Intensive Care Med. 2014 May; 40(5):683-90.
Score: 0.016
-
Quan D, Hammack BN, Kittelson J, Gilden DH. Improvement of postherpetic neuralgia after treatment with intravenous acyclovir followed by oral valacyclovir. Arch Neurol. 2006 Jul; 63(7):940-2.
Score: 0.009
-
Hussain Y, Malhotra S, Sperry BW, Shu F, Ananthasubramaniam K, Desai U, Egolum U, Fernandez J, Freimer M, Mauricio E, Quan D, Small R, Capocelli K, Roblin S, Bender S, Jay PY, Yureneva E, Zolty R. Impact of patisiran on polyneuropathy of hereditary transthyretin amyloidosis in patients with a V122I or T60A variant: a phase IV multicenter study. Ann Med. 2025 Dec; 57(1):2537347.
Score: 0.009
-
Quan D, Pelak V, Tanabe J, Durairaj V, Kleinschmidt-Demasters BK. Spinal and cranial hypertrophic neuropathy in multiple sclerosis. Muscle Nerve. 2005 Jun; 31(6):772-9.
Score: 0.008
-
Jacoby E, Quan D, Todd E, Shortt J, Smith H, Rafaels N, Crooks K. Prevalence of Pathogenic Transthyretin Gene Variants in the Rocky Mountain Region. Muscle Nerve. 2025 Feb; 71(2):252-256.
Score: 0.008
-
Quan D, Wellish M, Gilden DH. Topical ketamine treatment of postherpetic neuralgia. Neurology. 2003 Apr 22; 60(8):1391-2.
Score: 0.007
-
Quan D, Cohen JA. Clinical variant of familial amyloid polyneuropathy. Muscle Nerve. 2002 Sep; 26(3):417-20.
Score: 0.007
-
Barohn RJ, Gajewski B, Pasnoor M, Brown A, Herbelin LL, Kimminau KS, Mudaranthakam DP, Jawdat O, Dimachkie MM, Iyadurai S, Stino A, Kissel J, Pascuzzi R, Brannagan T, Wicklund M, Ahmed A, Walk D, Smith G, Quan D, Heitzman D, Tobon A, Ladha S, Wolfe G, Pulley M, Hayat G, Li Y, Thaisetthawatkul P, Lewis R, Biliciler S, Sharma K, Salajegheh K, Trivedi J, Mallonee W, Burns T, Jacoby M, Bril V, Vu T, Ramchandren S, Bazant M, Austin S, Karam C, Hussain Y, Kutz C, Twydell P, Scelsa S, Kushlaf H, Wymer J, Hehir M, Kolb N, Ralph J, Barboi A, Verma N, Ahmed M, Memon A, Saperstein D, Lou JS, Swenson A, Cash T. Patient Assisted Intervention for Neuropathy: Comparison of Treatment in Real Life Situations (PAIN-CONTRoLS): Bayesian Adaptive Comparative Effectiveness Randomized Trial. JAMA Neurol. 2021 01 01; 78(1):68-76.
Score: 0.006
-
Adams D, Polydefkis M, González-Duarte A, Wixner J, Kristen AV, Schmidt HH, Berk JL, Losada López IA, Dispenzieri A, Quan D, Conceição IM, Slama MS, Gillmore JD, Kyriakides T, Ajroud-Driss S, Waddington-Cruz M, Mezei MM, Planté-Bordeneuve V, Attarian S, Mauricio E, Brannagan TH, Ueda M, Aldinc E, Wang JJ, White MT, Vest J, Berber E, Sweetser MT, Coelho T. Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study. Lancet Neurol. 2021 01; 20(1):49-59.
Score: 0.006
-
González-Duarte A, Berk JL, Quan D, Mauermann ML, Schmidt HH, Polydefkis M, Waddington-Cruz M, Ueda M, Conceição IM, Kristen AV, Coelho T, Cauquil CA, Tard C, Merkel M, Aldinc E, Chen J, Sweetser MT, Wang JJ, Adams D. Analysis of autonomic outcomes in APOLLO, a phase III trial of the RNAi therapeutic patisiran in patients with hereditary transthyretin-mediated amyloidosis. J Neurol. 2020 Mar; 267(3):703-712.
Score: 0.006
-
Kelmenson DA, Quan D, Moss M. What is the diagnostic accuracy of single nerve conduction studies and muscle ultrasound to identify critical illness polyneuromyopathy: a prospective cohort study. Crit Care. 2018 12 17; 22(1):342.
Score: 0.005
-
Kelmenson DA, Held N, Allen RR, Quan D, Burnham EL, Clark BJ, Ho PM, Kiser TH, Vandivier RW, Moss M. Outcomes of ICU Patients With a Discharge Diagnosis of Critical Illness Polyneuromyopathy: A Propensity-Matched Analysis. Crit Care Med. 2017 Dec; 45(12):2055-2060.
Score: 0.005
-
Kelmenson DA, Quan D, Nordon-Craft A, Malone D, Schenkman M, Moss M. Electrophysiological abnormalities can differentiate pre-hospital discharge functional status in critically ill patients with normal strength. Intensive Care Med. 2016 Sep; 42(9):1504-5.
Score: 0.005
-
Lozowska D, Liewluck T, Quan D, Ringel SP. Exertional rhabdomyolysis associated with high intensity exercise. Muscle Nerve. 2015 Dec; 52(6):1134-5.
Score: 0.004
-
Oskarsson B, Quan D, Rollins YD, Neville HE, Ringel SP, Arciniegas DB. Using the Frontal Assessment Battery to identify executive function impairments in amyotrophic lateral sclerosis: A preliminary experience. Amyotroph Lateral Scler. 2010; 11(1-2):244-7.
Score: 0.003
-
Levi ME, Quan D, Ho JT, Kleinschmidt-Demasters BK, Tyler KL, Grazia TJ. Impact of rituximab-associated B-cell defects on West Nile virus meningoencephalitis in solid organ transplant recipients. Clin Transplant. 2010 Mar-Apr; 24(2):223-8.
Score: 0.003
-
Taylor MRG, Ku L, Slavov D, Cavanaugh J, Boucek M, Zhu X, Graw S, Carniel E, Barnes C, Quan D, Prall R, Lovell MA, Mierau G, Ruegg P, Mandava N, Bristow MR, Towbin JA, Mestroni L. Danon disease presenting with dilated cardiomyopathy and a complex phenotype. J Hum Genet. 2007; 52(10):830-835.
Score: 0.002
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|